Systemic Lupus Erythematosis (SLE)
SLE affects people across the European population. The SLE burden in terms of individuals and health economies remains significant in the absence of sufficient highly effective therapeutics, predictive biomarkers and optimized treatment strategies. FOREUM Foundation for Research in Rheumatology recognized the growing burden of SLE and the substantial unmet therapeutic need in this area and has therefore initiated this call.
30 letters of intent were received, peer reviewed and thoroughly evaluated. As a result, four projects are being funded.
For information on the funded projects, please click in the top navigation bar on "funded research".